169 related articles for article (PubMed ID: 23024026)
1. B4GALT1 gene knockdown inhibits the hedgehog pathway and reverses multidrug resistance in the human leukemia K562/adriamycin-resistant cell line.
Zhou H; Zhang Z; Liu C; Jin C; Zhang J; Miao X; Jia L
IUBMB Life; 2012 Nov; 64(11):889-900. PubMed ID: 23024026
[TBL] [Abstract][Full Text] [Related]
2. Glycomic alterations are associated with multidrug resistance in human leukemia.
Zhang Z; Zhao Y; Jiang L; Miao X; Zhou H; Jia L
Int J Biochem Cell Biol; 2012 Aug; 44(8):1244-53. PubMed ID: 22579717
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
Lin M; Hu J; Liu T; Li J; Chen B; Chen X
Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
[TBL] [Abstract][Full Text] [Related]
4. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTĪ activity.
Song YN; Guo XL; Zheng BB; Liu XY; Dong X; Yu LG; Cheng YN
Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141
[TBL] [Abstract][Full Text] [Related]
5. Targeting biliverdin reductase overcomes multidrug resistance in leukemia HL60 cells.
Kim SS; Seong S; Lim SH; Kim SY
Anticancer Res; 2013 Nov; 33(11):4913-9. PubMed ID: 24222129
[TBL] [Abstract][Full Text] [Related]
6. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
Li J; Xu LZ; Yao JJ; Guo WJ; Xia P; Chen Y
Acta Pharmacol Sin; 2001 Nov; 22(11):1023-7. PubMed ID: 11749795
[TBL] [Abstract][Full Text] [Related]
7. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
Qi X; Chang Z; Song J; Gao G; Shen Z
Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
[TBL] [Abstract][Full Text] [Related]
9. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the microtubules assembly of multidrug-resistant human leukemic cells].
Hara N
Hokkaido Igaku Zasshi; 1995 Jul; 70(4):573-89. PubMed ID: 7590604
[TBL] [Abstract][Full Text] [Related]
11. B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1.
Zhou H; Ma H; Wei W; Ji D; Song X; Sun J; Zhang J; Jia L
Cell Death Dis; 2013 Jun; 4(6):e654. PubMed ID: 23744354
[TBL] [Abstract][Full Text] [Related]
12. Expression profile of Notch-related genes in multidrug resistant K562/A02 cells compared with parental K562 cells.
Yan S; Ma D; Ji M; Guo D; Dai J; Zhao P; Ji C
Int J Lab Hematol; 2010 Apr; 32(2):150-8. PubMed ID: 19302234
[TBL] [Abstract][Full Text] [Related]
13. Acquired multidrug resistance in human K562/ADM cells is associated with enhanced autophagy.
Cheng J; Chen J; Xie B; Wei HL
Toxicol Mech Methods; 2013 Nov; 23(9):678-83. PubMed ID: 24024664
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
15. CIAPIN1 confers multidrug resistance through up-regulation of MDR-1 and Bcl-L in LoVo/Adr cells and is independent of p53.
Zhang YF; Li XH; Shi YQ; Wu YY; Li N; He Q; Ji Q; Wang RQ; Yang SM; Fang DC
Oncol Rep; 2011 Apr; 25(4):1091-8. PubMed ID: 21240465
[TBL] [Abstract][Full Text] [Related]
16. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
17. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
18. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line.
Liu Y; Xie KM; Yang GQ; Bai XM; Shi YP; Mu HJ; Qiao WZ; Zhang B; Xie P
Cancer Chemother Pharmacol; 2010 Aug; 66(3):433-9. PubMed ID: 19936984
[TBL] [Abstract][Full Text] [Related]
19. [Enhancive effect of PLK1 gene silencing on sensitivity of K562/A02 cells to adriamycin].
Liu L; Zhang M; Zou P; Tian L; Liu F
Ai Zheng; 2006 Apr; 25(4):404-8. PubMed ID: 16613670
[TBL] [Abstract][Full Text] [Related]
20. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
